News From The Journal Of The National Cancer Institute, Jan. 13
 

Lapatinib Reduces Mammary Tumor Development in Mouse Model of Breast Cancer Lapatinib delayed tumor development in a mouse model of hormone receptor-negative breast cancer and reduced the number of tumors per animal compared with mice treated only with vehicle (an inert solution lacking lapatinib).

More...